What is a stock summary page? Click here for an overview.
Business Description
BioArctic AB
ISIN : SE0010323311
Share Class Description:
OSTO:BIOA B: Class BCompare
Compare
Traded in other countries / regions
BIOA B.Sweden0RV2.UKBRCTF.USAB9A.Germany IPO Date
2017-10-12Description
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.46 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.29 | |||||
| Altman Z-Score | 47.38 | |||||
| Beneish M-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 123.3 | |||||
| 3-Year EBITDA Growth Rate | -14.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.7 | |||||
| 3-Year FCF Growth Rate | -29.8 | |||||
| 3-Year Book Growth Rate | 4.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 86.85 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.57 | |||||
| 9-Day RSI | 32.67 | |||||
| 14-Day RSI | 35.69 | |||||
| 3-1 Month Momentum % | 21.7 | |||||
| 6-1 Month Momentum % | 53.19 | |||||
| 12-1 Month Momentum % | 12.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.75 | |||||
| Quick Ratio | 5.75 | |||||
| Cash Ratio | 2.92 | |||||
| Days Sales Outstanding | 0.32 | |||||
| Days Payable | 404 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.52 | |||||
| Operating Margin % | -88.8 | |||||
| Net Margin % | -68.81 | |||||
| FCF Margin % | -122.92 | |||||
| ROE % | -18.51 | |||||
| ROA % | -15.65 | |||||
| ROIC % | -43.23 | |||||
| 3-Year ROIIC % | -19.92 | |||||
| ROC (Joel Greenblatt) % | -50.35 | |||||
| ROCE % | -18.89 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 18.46 | |||||
| Shiller PE Ratio | 331.04 | |||||
| PS Ratio | 63.36 | |||||
| PB Ratio | 18.22 | |||||
| Price-to-Tangible-Book | 18.21 | |||||
| EV-to-EBIT | -84.59 | |||||
| EV-to-Forward-EBIT | 10.92 | |||||
| EV-to-EBITDA | -84.59 | |||||
| EV-to-Forward-EBITDA | 40.01 | |||||
| EV-to-Revenue | 61.68 | |||||
| EV-to-Forward-Revenue | 7.65 | |||||
| EV-to-FCF | -52 | |||||
| Price-to-GF-Value | 0.31 | |||||
| Price-to-Projected-FCF | 24.57 | |||||
| Price-to-Net-Current-Asset-Value | 20.55 | |||||
| Price-to-Net-Cash | 55.07 | |||||
| Earnings Yield (Greenblatt) % | -1.18 | |||||
| FCF Yield % | -1.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
BioArctic AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 257.352 | ||
| EPS (TTM) (kr) | -2 | ||
| Beta | 0.15 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 2 | ||
| Volatility % | 62.08 | ||
| 14-Day RSI | 35.69 | ||
| 14-Day ATR (kr) | 10.359336 | ||
| 20-Day SMA (kr) | 205.5 | ||
| 12-1 Month Momentum % | 12.72 | ||
| 52-Week Range (kr) | 137.7 - 271.4 | ||
| Shares Outstanding (Mil) | 88.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioArctic AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioArctic AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioArctic AB Frequently Asked Questions
What is BioArctic AB(OSTO:BIOA B)'s stock price today?
The current price of OSTO:BIOA B is kr184.50. The 52 week high of OSTO:BIOA B is kr271.40 and 52 week low is kr137.70.
When is next earnings date of BioArctic AB(OSTO:BIOA B)?
The next earnings date of BioArctic AB(OSTO:BIOA B) is 2025-05-16 Est..
Does BioArctic AB(OSTO:BIOA B) pay dividends? If so, how much?
BioArctic AB(OSTO:BIOA B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers